Teva Pharmaceutical Industries Ltd.
TEVA Healthcare Drug Manufacturers Specialty & Generic
In the quarter to June 2026, revenue was flat, EPS fell 296.0%, free cash flow grew 121.4% and total debt fell 3.69%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
Follow TEVA
Teva Pharmaceutical Industries Ltd. (TEVA) P/E ratio
As of 16 October 2026, Teva Pharmaceutical Industries Ltd. (TEVA) trades at a P/E ratio of 65.9×. Over the past ten years it has ranged from 0.0× (September 2025) to 1,648× (June 2017); the current reading is higher than 96% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 19.2× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 25.2× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 21.1× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 535× | 1,400.90% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 53.8× | 144.61% |
| Mar 2026 | 22.0× | (12.65%) |
| Dec 2025 | 25.2× | (21.50%) |
| Sep 2025 | 32.1× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| VTRS Viatris Inc. compare | n/m |
| ELAN Elanco Animal Health Incorporated compare | n/m |
| ZTS Zoetis Inc. compare | 13.0× |
| UTHR United Therapeutics Corporation compare | 17.6× |
| NBIX Neurocrine Biosciences, Inc. compare | 19.2× |
| HLN Haleon PLC Sponsored ADR compare | 22.6× |
| TAK Takeda Pharmaceutical Co. compare | 29.6× |
| RDY Dr. Reddy's Laboratories Ltd compare | 32.9× |
| TEVA Teva Pharmaceutical Industries Ltd. | 65.9× |
| Drug Manufacturers Specialty & Generic industry median | 19.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)